The following video is part of our "Motley Fool Conversations" series, in which analyst John Reeves and advisor David Meier discuss topics across the investing world.
Dave and John consider whether Merck will be a dominant company 10 years from now. Dave feels it's a solid company that may not be the innovator it once was. After considering its competitive position, Dave offers up his long-term outlook.
David Meier and John Reeves have no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Motley Fool newsletter services recommend Pfizer. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.